Jim Mazzola | Vice President and Investor Relations |
Helen Torley | President and Chief Executive Officer |
Laurie Stelzer | Senior Vice President and Chief Financial Officer |
Demetrius Chondros | Chief Medical Officer |
Jason Butler | JMP Securities |
Dana Flanders | Goldman Sachs |
Jessica Fye | JPMorgan |
Shawn Egan | Citigroup |
Gena Wang | Barclays |
Arlinda Lee | Canaccord Genuity |
Gobind Singh | BMO |
Good afternoon and welcome to the Halozyme Therapeutics First Quarter 2018 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this call is being recorded. It is now my pleasure to introduce your host, Jim Mazzola, Vice President of Investor Relations at Halozyme.